相关实验视频
Updated: Jan 30, 2026

06:41
Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
13.0K
开发和内部验证可解释的机器学习模型,以预测体外膜氧化后的凝血病:一个回顾性多中心研究
Zhen Chen1, Zhenhua Zeng2, Genglong Liu3,4
1Department of Intensive Care Unit, The Eighth Affiliated Hospital, Southern Medical University (The First People's Hospital of Shunde, Foshan), Guangdong Province, Foshan, 528308, People's Republic of China.
Scandinavian journal of trauma, resuscitation and emergency medicine
|January 29, 2026
概括
一个新的机器学习模型,ECMO-IC指数,使用常规临床数据准确预测体外膜氧化诱导的凝血病 (ECMO-IC). 该工具有助于识别有风险的患者和潜在的可修改因素,以改善ECMO管理.
科学领域:
- 关键护理医学 关键护理医学
- 生物医学信息学 生物医学信息学
- 医疗保健中的机器学习
背景情况:
- 身体外膜氧化诱导的凝血病 (ECMO-IC) 是一种严重的并发症,影响患者的结果,需要更换氧化器.
- 目前的方法缺乏可靠的机器学习 (ML) 模型,用于早期ECMO-IC识别.
研究的目的:
- 开发一种可靠,准确和可解释的ML模型,以使用常规临床数据估计ECMO-IC风险.
- 确定与ECMO-IC相关的可修改的临床因素.
主要方法:
- 利用Boruta算法从两个中心的队列中选择特征 (266名患者,2015-2024年).
- 使用12个ML算法实现了一个共识预测模型 (ECMO-IC指数).
- 通过引导,交叉验证,子组分析,RCS回归和SHAP进行解释来评估模型性能.
主要成果:
- 包含9个变量 (例如PLT,乳酸盐,APACHE II) 的ECMO-IC指数实现了平均AUC为0.815.
- SHAP分析突出了关键预测因素和可视化风险.
- 确定了关键特征的非线性关系和拐点.
结论:
- 为ECMO-IC风险预测开发并验证了一种优化,可解释的ML模型 (ECMO-IC指数).
- 该模型包含可修改的参数,提供易于使用的诊断工具.
- 潜在的应用包括加强ECMO患者的临床管理.
更多相关视频
相关概念视频
Reliability and Validity
13.9K
Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways.
13.9K
Internal Energy
36.7K
The total of all possible kinds of energy present in a substance is called the internal energy (U), sometimes symbolized as E. Suppose a system with initial internal energy, Uinitial, undergoes a change in energy (transfer of work or heat), and the final internal energy of the system is Ufinal. Change in internal energy equals the difference between Ufinal and Uinitial.
36.7K
Simplified Synchronous Machine Model
772
The Synchronous Machine Model is a fundamental tool in analyzing and ensuring the transient stability of power systems. This model simplifies the representation of a synchronous machine under balanced three-phase positive-sequence conditions, assuming constant excitation and ignoring losses and saturation. The model is pivotal for understanding the behavior of synchronous generators connected to a power grid, particularly during transient events.
In this model, each generator is connected to a...
In this model, each generator is connected to a...
772
Wind Turbine Machine Models
600
In the growing field of wind energy, incorporating wind turbine models into transient stability analysis is essential. Induction and synchronous machines are the primary models used, with induction machines being prevalent due to their simplicity and reliability.
Induction machines interact through the rotating magnetic field generated by the stator and the rotor. The key parameter is slip, which is the difference between synchronous speed and rotor speed relative to synchronous speed. Slip is...
Induction machines interact through the rotating magnetic field generated by the stator and the rotor. The key parameter is slip, which is the difference between synchronous speed and rotor speed relative to synchronous speed. Slip is...
600
Internal Receptors
74.6K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.6K
In Vitro Drug Release Testing: Overview, Development and Validation
331
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
331

